Eric Lefkofsky Is Using Technology To Aid In Cancer Treatment

People are stricken with cancer each year all around the world, and in recent reports, there are more than 15 million individuals in the United States that are diagnosed with cancer today. It is thanks to the work of individuals like Eric Lefkofsky, co-founder of Tempus, that technology advancements are coming to the medical industry and a much faster rate than ever. Tempus is a tech company that uses software to analyze and collect data to help fight cancer in the future.

Tempus is a platform that is going to change the way doctors are able to operate on their patients. For the longest time, patients and clinical data has been widely disorganized, and even the data that is organized is hard to use in any effective manner. This is especially true when considering that each individual is different and must be handled differently when it comes to their treatment. But there is no structure to notes that have been made on subjects and certainly no effective way to find and use that data. Tempus is fixing this problem by creating a structure for all data specific to each patient, which could potentially be life-saving for people all over the world.

Thanks to the impressive success of Tempus thus far, the sequencing process of molecular and genomic data has continued to decrease in cost. This allows it to be available to many more people, which is a great thing as everyone is entitled to live a healthy life free of harm.

Ever since graduating from college in Michigan, Eric Lefkofsky has been driven to not only change the world but improve it. Eric has found many successes in his life through his business efforts, but whats more important than what he has achieved is what he does with it. Not only did Eric and his wife start up the Lefkofsky foundation, but they regularly donate to organizations and various charities working to make the world a better place. They have donated millions over the past decade, and they even plan to donate upwards of 50 percent of everything they gain to help people all over the world.

Learn More: lefkofskyfoundation.com/

Dr. David Samadi Rewrites The Book On Performing Urologic Surgeries

Dr. David Samadi is a board-certified urologist whose specialties are diagnosing and treating bladder cancer, kidney cancer, prostate cancer, and other urologic diseases. He practices at Lenox Hill Hospital in New York City where he is the chief of robotic surgery and the chairman of urology. Most of his surgeries are minimally invasive from which patients can quickly recover.

It was in 1994 that Dr. David Samadi earned his medical degree. After attending Stony Brook University, where he earned his bachelor’s degree in biochemistry, he earns his M.D. by attending the Stony Brook School of Medicine. After graduating he did his postgraduate work at two hospitals, the Albert Einstein College of Medicine and the Montefiore Medical Center. After this training he went to Memorial Kettering Cancer Center where he did a fellowship in proctology. It was at the Henri Mondor Hospital Creteil, located in Creteil, France, that his fellowship in robotic surgery was performed.

Over the course of his professional career Dr. David Samadi has performed surgery in over 45 nations. Some of the hospital he has performed robotic surgery is the Mt. Sinai School of Medicine as well as Columbia Presbyterian Hospital. He has through time built a team of medical professionals that assist him when he is diagnosing urologic diseases and while performing surgery.
Due to his expertise he was brought in by Fox News to host a medical show, “Sunday Housecall”, from 2011 to 2016. He is now the host of a radio show that he began in 2015. He also established a website, Samadi MD.com, on which he posts articles about health-related matters. He is perhaps the only celebrity urologist in the world.

The type of surgery that most urologists perform can result in men having side effects after the surgery such as impotence and incontinence. Dr. David Samadi is currently creating a new technique without these issues, which he abbreviates as SMART. SMART stands for Samadi Modified Advanced Robotic Technique. His approach doesn’t damage the nerves in the area that is being operated on and so there are no side effects. He expects to prove this technique works and publish the results in the near future.

Dr. David Samadi is originally from Iran and was born in a Jewish community. When the Iranian Revolution occurred in 1979 he and his younger brother fled this nation for Belgium. By way of London they eventually emigrated to America and settled in Roslyn, New York.

Dr. David Samadi Info: www.crunchbase.com/person/dr-david-samadi